Related Experiment Video
Updated: Jun 20, 2025

05:49
Author Spotlight: Deciphering Electrical Networks Behind Complex Brain Activities and Disorders
Published on: November 1, 2024
767
Minimal important difference of the Migraine Disability Assessment (MIDAS): Longitudinal data from the DMKG Headache
Ruth Ruscheweyh1,2, Stefanie Förderreuther1, Tobias Freilinger3
1Department of Neurology, LMU University Hospital, LMU Munich, Munich, Germany.
Cephalalgia : an International Journal of Headache
|July 21, 2024
Summary
A reduction of 30% in Migraine Disability Assessment (MIDAS) scores for severe migraine patients, or 4 points for moderate cases, signifies a meaningful improvement. These findings help interpret MIDAS scores in clinical practice.
Area of Science:
- Neurology
- Clinical Research
- Patient-Reported Outcomes
Background:
- The Migraine Disability Assessment (MIDAS) is a widely utilized tool for assessing migraine-related disability.
- Limited data exist on the minimal important difference (MID) for MIDAS scores, hindering interpretation of patient-perceived changes.
- The German Migraine and Headache Society (DMKG) Headache Registry provides a valuable dataset for this research.
Purpose of the Study:
- To determine the minimal important difference (MID) of the MIDAS score in a tertiary headache care population.
- To establish thresholds for clinically meaningful improvement in MIDAS scores based on patient perception.
- To enhance the interpretability of MIDAS scores in clinical practice and research.
Main Methods:
- Utilized data from the DMKG Headache Registry (DRKS 00021081).
- Employed the Patient Global Impression of Change (PGIC) as an anchor to define meaningful improvement.
- Applied average change and receiver operating characteristic (ROC) curve methods to calculate the MID for MIDAS scores.
Main Results:
- Included 1218 adult migraine patients (40.2 ± 12.8 years, 85.6% female).
- For patients with baseline MIDAS >20 (grade IV), the MID was estimated between -29.4% and -33.2% using PGIC "somewhat improved" as the anchor.
- For patients with baseline MIDAS 6-20 (grades II-III), the MID was between -3.5 and -4.5 points using PGIC "much improved" as the anchor.
Conclusions:
- The minimal important difference (MID) for MIDAS was estimated at approximately -30% for patients with a baseline MIDAS >20.
- For patients with a baseline MIDAS of 6-20, the MID was estimated at -4 points.
- These findings provide crucial benchmarks for interpreting MIDAS score changes in clinical settings.

